All Pharma News
Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq

Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq
BUSINESSWIRE
07 Mar 2024
Share Share
Ongoing Results From a Dose Expansion Cohort of CYT-0851

Ongoing Results From a Dose Expansion Cohort of CYT-0851
BUSINESSWIRE
12 Oct 2023
Share Share
Cyteir calls it quits after months of cost cutting

Cyteir calls it quits after months of cost cutting
Max Bayer FIERCE BIOTECH
30 Jun 2023
Share Share
Cyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program

Cyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program
BUSINESSWIRE
30 Jun 2023
Share Share
Preliminary Result with CYT-0851 in Advanced Solid Tumors Show Clinical Activity

Preliminary Result with CYT-0851 in Advanced Solid Tumors Show Clinical Activity
BUSINESSWIRE
03 Jun 2023
Share Share
Fusion and Cyteir refocus pipelines; Nona collaborating with PharmaEssentia

Fusion and Cyteir refocus pipelines; Nona collaborating with PharmaEssentia
Tyler Patchen ENDPTS
12 May 2023
Share Share
Fusion, Cyteir refocus pipelines to funnel cash toward best bets

Fusion, Cyteir refocus pipelines to funnel cash toward best bets
Max Bayer FIERCE BIOTECH
11 May 2023
Share Share
Cyteir Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

Cyteir Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
BUSINESSWIRE
23 Mar 2023
Share Share
Cyteir Therapeutics Promotes David Gaiero to Chief Financial Officer

Cyteir Therapeutics Promotes David Gaiero to Chief Financial Officer
BUSINESSWIRE
06 Feb 2023
Share Share
Cyteir lets go of 35 staffers, goes all in on ovarian cancer

Cyteir lets go of 35 staffers, goes all in on ovarian cancer
Amber Tong ENDPTS
20 Jan 2023
Share Share